Clinical Trials Logo

Clinical Trial Summary

The objective of this human randomized, double blind, placebo-control (RDBPC) study is to evaluate the efficacy of a 0.2% chlorhexidine (CHX) gel on reducing bacterial load and peri-implant inflammation at implant-abutment interface during the early healing stage.Thirty-six healthy patients (mean age 52,28 years; range 29-75 years) without a significant past medical anamnesis, all non-smokers, will be recruited as candidates for single implant placement and prosthetic rehabilitation.Patients will be randomly divided in group A (control) and group B (test) as indicated by the randomization chart. All Implants (Cortex classic, Shalomi, Israel)would be inserted by two skilled operators who followed a two-stage protocol and placed them according to the manufacturer's instructions.Eventually, all patients will be rehabilitated with a single implant-supported crown. During all the stages either a gel containing 0.20% CHX (Plak ®Gel; Polifarma Wellness Srl, Rome, Italy) or a placebo gel (Placebo, Polifarma Wellness Srl, Rome, Italy) will be used. The two gels are perfectly alike in packaging, color and smell and nobody knew the exact location of placebo or test gel, which will be revealed, only after data collection would be performed, by the person who prepared them. A or B gel will be placed on the internal connection abutments and then a cover screw would be inserted. Finally, the site would be sutured with non-absorbable nylon sutures. Cone Beam Computed Tomography evaluation (CBCT) (VatechIpax 3D PCH-6500, Fort Lee, NJ USA) would be performed both for pre-operative and post-surgical implant placement. Both gels will be given to the patients, according to the protocol, and applied 2 times/day until suture removal after 7 days. Soft tissue biopsies would be performed by means of a circular scalpel (5.5 mm in diameter) at the implant insertion (T0) and after two months of healing (second stage surgery)(T1) to analyze the peri-implant inflammatory infiltrate and the micro-vessel density (MVD) in both groups. All the radiographs taken during the study time points would be analysed to measure the bone resorption after 1 year or on other studt time points.


Clinical Trial Description

The objective of this human randomized, double blind, placebo-control (RDBPC) study is to evaluate the efficacy of a 0.2% chlorhexidine (CHX) gel on reducing bacterial load and peri-implant inflammation at implant-abutment interface during the early healing stage. Thirty-six healthy patients (mean age 52,28 years; range 29-75 years) without a significant past medical anamnesis, all non-smokers, will be recruited as candidates for single implant placement and prosthetic rehabilitation.Patients will be randomly divided in group A (control) and group B (test) as indicated by the randomization chart. The randomization of this prospective, randomized-controlled, double blind study was obtained using computer generated random numbers, centralized with sequentially sealed opaque envelopes provided by the study adviser.The surgeon will open the sealed envelope containing the randomized group only after having inserted the implant.During the first evaluation, all subjects will be clinically examined: radiographs, plaque and bleeding scores would be carried out for diagnostic evaluation; then the patients would be scheduled for surgery procedures. All Implants (Cortex classic, Shalomi, Israel) would be inserted by two skilled operators who will follow a two-stage protocol and would place them according to the manufacturer's instructions. Before surgery all the patients would be subject to applications of chlorhexidine digluconate solution 0.2% for 2 minutes to obtain lower bacterial load and local anesthesia would be given with Articaine® (Ubistesin 4% - Espe Dental AG Seefeld, Germany) associated with epinephrine (1:100.000). Eventually, all patients would be rehabilitated with a single implant-supported crown. During all the stages either a gel containing 0.20% CHX (Plak ®Gel; Polifarma Wellness Srl, Rome, Italy) or a placebo gel (Placebo, Polifarma Wellness Srl, Rome, Italy) would be used. The two gels are perfectly alike in packaging, colour and smell and nobody knows the exact location of placebo or test gel, which would be revealed, only after data collection would be performed, by the person who prepared them. A or B gel would be placed on the internal connection abutments and then a cover screw would be inserted. Finally, the site would be sutured with non-absorbable nylon sutures. Cone Beam Computed Tomography evaluation (CBCT) (VatechIpax 3D PCH-6500, Fort Lee, NJ USA) would be performed both for pre-operative and post-surgical implant placement. All patients will recieve antibiotic therapy, 2g/day for 6 days (Augumentin®; Glaxo-Smithkline Beecham, Brentford, UK).The post-operative pain would be controlled with NSAIDs, and oral hygiene instructions would be given. Both gels would be given to the patients, according to the protocol, and applied 2 times/day until suture removal after 7 days. Soft tissue biopsies would be performed by means of a circular scalpel (5.5 mm in diameter) at the implant insertion (T0) and after two months of healing (second stage surgery)(T1) to analyze the peri-implant inflammatory infiltrate and the micro-vessel density (MVD) in both groups. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03431766
Study type Interventional
Source G. d'Annunzio University
Contact bruna sinjari, dds, phd
Phone +393927471479
Email b.sinjari@unich.it
Status Recruiting
Phase N/A
Start date November 17, 2015
Completion date June 30, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04073654 - SA Versus SOI Surfaces for Single Implant-supported Crown N/A
Recruiting NCT06374342 - BONE SUBSTITUTES OUTCOMES
Not yet recruiting NCT04345250 - Bone Response to Exercise and Energy Restriction in Young Adults N/A
Completed NCT05533502 - Combination Plant-Based Protein and Marine-Based Multi-Mineral Supplement and Bone Remodeling in Young Adults N/A
Completed NCT04279392 - Healthy Body, Healthy Bones After Bariatric Surgery Trial Phase 1/Phase 2
Recruiting NCT04548258 - Bone Changes Assessment in Screw-Retained Maxillary Complete Denture With Electric Welded Framework Versus Cast One N/A
Withdrawn NCT04331028 - Effect of Shock-wave Therapy on the Resorption and Bone Formation in Maxillary Postextraction Sockets N/A
Completed NCT06383117 - Understanding Effects of Calcium on the Gut-Bone Axis N/A
Recruiting NCT06334159 - Guided Bone Regeneration Using Fixed vs Non-Fixed Resorbable Collagen Membranes N/A
Completed NCT03888339 - Influence of Abutment Shape on Peri-implant Marginal Bone Loss N/A
Completed NCT03026894 - Association of Force Distribution and Bone Resorption N/A
Completed NCT02470611 - Sodium Alendronate in Non Surgical Periodontal Therapy Phase 4
Completed NCT00297830 - Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation Phase 2/Phase 3
Recruiting NCT04141215 - Allogeneic Bone Paste Versus Allogeneic Bone Powder N/A
Recruiting NCT05018130 - Bio-Integrative Versus Metallic Screws for Calcaneus Osteotomies N/A
Completed NCT04790019 - The Effects of Low Energy Availability and High Impact Jumping on Markers of Bone (re)Modelling in Females N/A
Recruiting NCT03889587 - Innervation of Vascularized Iliac Transplant Avoids Resorption in Jaw Bone Reconstruction N/A
Completed NCT05804604 - Bone Intake Proteins and Muscle Mass Deficiency in Proximal Femur Fractures
Terminated NCT03089619 - Alveolar Management Following Teeth Extraction Phase 4
Completed NCT06049823 - Alveolar Ridge Preservation With Different Grafting Strategies N/A